These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3656119)

  • 21. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential changes in behavior induced by continuous infusions of amphetamine in rats.
    Gately PF; Segal DS; Geyer MA
    Psychopharmacology (Berl); 1987; 91(2):217-20. PubMed ID: 3107035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization.
    Aizenstein ML; Segal DS; Kuczenski R
    Neuropsychopharmacology; 1990 Aug; 3(4):283-90. PubMed ID: 1976010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.
    Kleinrok Z; Wielosz M; Przegaliński E
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):477-84. PubMed ID: 1172420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of amphetamine-induced locomotor stereotypy in an open field.
    Mueller K; Kunko PM; Whiteside D; Haskett C
    Psychopharmacology (Berl); 1989; 99(4):501-7. PubMed ID: 2594917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses of neurons in dorsal striatum during amphetamine-induced focused stereotypy.
    Rebec GV; White IM; Puotz JK
    Psychopharmacology (Berl); 1997 Apr; 130(4):343-51. PubMed ID: 9160850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration of D-amphetamine or restraint stress.
    Camp DM; Robinson TE
    Behav Brain Res; 1988 Sep; 30(1):69-88. PubMed ID: 2458742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy.
    Segal DS
    Brain Res; 1976 Nov; 116(2):267-76. PubMed ID: 135600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Segal DS
    Adv Biochem Psychopharmacol; 1975; 13():247-62. PubMed ID: 1171583
    [No Abstract]   [Full Text] [Related]  

  • 31. Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic D-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines.
    Camp DM; Robinson TE
    Behav Brain Res; 1988 Sep; 30(1):55-68. PubMed ID: 2458741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two dissociable components of behavioral sensitization following repeated amphetamine administration.
    Leith NJ; Kuczenski R
    Psychopharmacology (Berl); 1982; 76(4):310-5. PubMed ID: 6812103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral concomitants of regional changes in the brain's biogenic amines after apomorphine and amphetamine.
    Schwarting RK; Huston JP
    Pharmacol Biochem Behav; 1992 Apr; 41(4):675-82. PubMed ID: 1594634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo measures of monoamines during amphetamine-induced behaviors in rats.
    Kuczenski R; Segal DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S37-50. PubMed ID: 2097672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral characterization of d- and l-amphetamine: neurochemical implications.
    Segal DS
    Science; 1975 Oct; 190(4213):475-7. PubMed ID: 1166317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nicotine on spontaneous and amphetamine-induced motor behaviors: the differences between nicotine tolerant and nontolerant rats.
    Kuo DY; Liu CN; Tsay JC; Chang CL; Cheng JT
    Chin J Physiol; 1998 Jun; 41(2):93-9. PubMed ID: 9801839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that a behavioral augmentation following repeated amphetamine administration does not involve peripheral mechanisms.
    Kuczenski R; Segal DS; Weinberger SB; Browne RG
    Pharmacol Biochem Behav; 1982 Sep; 17(3):547-53. PubMed ID: 6890688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and experimental factors in the behavioral response to repeated amphetamine.
    Browne RG; Segal DS
    Pharmacol Biochem Behav; 1977 May; 6(5):545-52. PubMed ID: 561406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Another look at amphetamine-induced stereotyped locomotor activity in rats using a new statistic to measure locomotor stereotypy.
    Mueller K; Hollingsworth EM; Cross DR
    Psychopharmacology (Berl); 1989; 97(1):74-9. PubMed ID: 2496430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats.
    Sahakian BJ; Robbins TW; Morgan MJ; Iversen SD
    Brain Res; 1975 Feb; 84(2):195-205. PubMed ID: 234275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.